Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women

Journal of Carcinogenesis

Volumn 6, Issue , 2007, Pages

  Yancy, Haile F ^a,b   Mason, Jacquline A ^b   Peters, Sharla ^b   Thompson III, Charles E ^c   Littleton, George K ^c   Jett, Marti ^d   Day, Agnes A ^a  

^a Criminal Justice and Applied Social and Political Sciences Department   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c HOWARD UNIVERSITY   (United States)

^d Walter Reed Army Institute for Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE CITRATE LYASE; BIOLOGICAL MARKER; CARBOHYDRATE BINDING PROTEIN; CASPASE RECRUITMENT DOMAIN 10; EPOXIDE HYDROLASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KRUPPEL LIKE FACTOR 4; PEPTIDYLPROLYL ISOMERASE; PROTEIN TYROSINE PHOSPHATASE; SERINE PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGALACTOSAMINE;

AFRICAN AMERICAN; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER MORTALITY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS POTENTIAL; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PHENOTYPE; RACE DIFFERENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOCIOECONOMICS;

EID: 34249820242     PISSN: None     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-6-8     Document Type: Article

References (56)

1. American Cancer Society Cancer Facts & Figures 2006 Atlanta: American Cancer Society 2006
2. Liotta LA Steeg PS Stetler-Stevenson WG Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation Cell 1991 64 2 327-36 10.1016/0092-8674(91)90642-C 1703045
3. American Cancer Society Cancer Facts & Figures for African Americans 2005-2006 Atlanta: American Cancer Society 2005
4. Ries L Eisner M SEER Cancer Statistics Review Bethesda, National Cancer Institute 1975-2001
5. Bradley CJ Given CW Roberts C Disparities in cancer diagnosis and survival Cancer 2001 91 178-188 10.1002/ 1097-0142(20010101)91:1<178::AID-CNCR23>3.0.CO;2-S 11148575
6. Bach PB Schrag D Brawley OW Galaznik A Yakren S Begg CB Survival of blacks and whites after a cancer diagnosis JAMA 2002 287 2106-2113 10.1001/jama.287.16.2106 11966385
7. Ghafoor A Jemal A Cokkinides V Cardinez C Murray T Samuels A Thun MJ Cancer statistics for African Americans CA Cancer J Clin 2002 52 326-341 12469762
8. Shavers V Brown M Racial and ethnic disparities in the receipt of cancer treatment J Natl Cancer Inst 2002 94 334-357 11880473
9. Smedley B Stith A Unequal treatment: Confronting racial and ethnic disparities in health care. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care Washington, DC, National Academy Press 2002
10. Chambers AF Groom AC MacDonald IC Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2002 2 563-72 10.1038/nrc865 12154349
11. Mason JA Yancy HF Lashley K Jett M Day AA Comparative study of matrix metalloproteinase expression between African American and Caucasian Women Journal of Carcinogenesis 2004 3 15 538270 15511301 10.1186/ 1477-3163-3-15
12. Eckhardt B Parker B van Laar RK Restall CM Natoli AL Tavaria MD Stanley KL Sloan EK Moseley JM Anderson RL Genomic Analysis of a Spontaneous Model of Breast Cancer Metastasis to Bone Reveals a Role for the Extracellular Matrix Mol Cancer Res 2005 3 1 1-13 15671244
13. National Breast Cancer Foundation Inc Based on information posted to the NBCF web site 2005 http://www.nationalbreastcancer.org/ signs_and_symptoms/index.html#breastcancertypes
14. Haffty B Silber A Matloff E Chung J Lannin D Racial Differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of Early Onset Breast Cancer patients: African American compared to White Women J Med Genet 2005 27
15. Lingrel J Orlowski J Shull M Price EM Molecular genetics of Na, K-ATPase Nucleic Acid Res Mol Biol 1990 89 37-38
16. Shull G Greeb J Lingrel J Molecular cloning of three distinct forms of the Na +, K +-ATPase β subunit from rat brain Biochemistry 1986 25 8125-8132 10.1021/bi00373a001 3028470
17. Martin-Vasallo P Dackowski W Emanuel J Levenson R Identification of a putative isoform of the Na, K-ATPase beta subunit J Biol Chem 1989 264 4613-4618 2538450
18. Good P Richter K Dawid IB A nervous system-specific isotype of the 13 subunit of Na +, K +-ATPase expressed during early development of Xenopus laevis Proc Natl Acad Sci 1990 87 9088-9092 55109 2174552 10.1073/pnas.87.23.9088
19. Young RM Lingrel J Tissue distribution of mRNAs encoding the ∼isoforms and 13 subunit of rat Na+, K+-ATPase Biochem Biophys Res Commun 1987 145 52-58 10.1016/0006-291X(87)91286-1 3036133
20. Ouellet V Provencher DM Maugard CM Le Page C Ren F Lussier C Novak J Ge B Hudson TJ Tonin PN Mes-Masson AM Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling Oncogene 2005 24 4672-4687 10.1038/sj.onc.1208214 15940270
21. Hofmann K The modular nature of apoptotic signaling proteins Cell Mol Life Sci 1999 55 1113-1128 10.1007/s000180050361 10442092
22. Bertin J DiStefano PS The PYRIN domain: A novel motif found in apoptosis and inflammation proteins Cell Death Differ 2000 7 1273-1274 10.1038/ sj.cdd.4400774 11270363
23. Staub E Dahl E Rosenthal A The DAPIN family: A novel domain links apoptotic and interferon response proteins Trends Biochem Sci 2001 26 83-85 10.1016/S0968-0004(00)01717-5 11166557
24. Wang L Guo Y Huang WJ Ke X Poyet JL Manji GA Merriam S Glucksmann A DiStefano PS Alnemri ES Bertin J Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B J Biol Chem 2001 276 2421405-21409 10.1074/jbc.M102488200 11259443
25. Schuh R Aicher W Gaul U Cote S Preiss A Maier D Seifert E Nauber U Schroder C Kemler R A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Krüppel, a Drosophila segmentation gene Cell 1986 47 1025-1032 10.1016/ 0092-8674(86)90817-2 3096579
26. Turner J Crossley M Mammalian Krüppel-like transcription factors: more than just a pretty finger Trends Biochem Sci 1999 24 236-240 10.1016/S0968-0004(99)01406-1 10366853
27. Yet SF McA'Nulty MM Folta SC Yen HW Yoshizumi M Hsieh CM Layne MD Chin MT Wang H Perrella MA Jain MK Lee ME Krüppel-like zinc finger protein is expressed in vascular endothelial cells and contains transcriptional activation and repression domains J Biol Chem 1998 273 1026-1031 10.1074/jbc.273.2.1026 9422764
28. Chen ZY Shie J Tseng C Up-regulation of gut-enriched krüppel-like factor by interferon-gamma in human colon carcinoma cells FEBS Lett 2000 477 67-72 10.1016/S0014-5793(00)01764-6 10899312
29. Shie JL Chen ZY O'Brien MJ Pestell RG Lee ME Tseng CC Role of gut-enriched Krüppel-like factor in colonic cell growth and differentiation Am J Physiol Gastrointest Liver Physiol 2000 279 G806-G814 11005769
30. Katz JP Perreault N Goldstein BG Actman L McNally SR Silberg DG Furth EE Kaestner KH Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach Gastroenterology 2005 128 4 935-45 10.1053/j.gastro.2005.02.022 15825076
31. Ohnishi S Ohnami S Laub F Aoki K Suzuki K Kanai Y Haga K Asaka M Ramirez F Yoshida T Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer Biochem Biophys Res Commun 2003 308 251-256 10.1016/S0006-291X(03)01356-1 12901861
32. Madden SL Cook BP Nacht M Weber WD Callahan MR Jiang Y Dufault MR Zhang X Zhang W Walter-Yohrling J Rouleau C Akmaev VR Wang CJ Cao X St Martin TB Roberts BL Teicher BA Klinger KW Stan RV Lucey B Carson-Walter EB Laterra J Walter KA Vascular gene expression in nonneoplastic and malignant brain Am J Pathol 2004 165 601-618 1618572 15277233
33. Bianchi F Hu J Pelosi G Cirincione R Ferguson M Ratcliffe C Di Fiore PP Gatter K Pezzella F Pastorino U Lung cancers detected by screening with spiral computed tomography have a malignant phenotype when analyzed by cDNA microarray Clin Cancer Res 2004 15 6023-6028 10.1158/ 1078-0432.CCR-04-0619
34. Delaria KA Muller DK Marlor CW Brown JE Das RC Roczniak SO Tamburini PP Characterization of placental bikunin, a novel human serine protease inhibitor J Biol Chem 1997 272 12209-12222 10.1074/jbc.272.18.12209 9115295
35. Mitchell KJ Pinson KI Kelly OG Brennan J Zupicich J Scherz P Leighton PA Goodrich LV Lu X Avery BJ Tate P Dill K Pangilinan E Wakenight P Tessier-Lavigne M Skarnes WC Functional analysis of secreted and transmembrane proteins critical to mouse development Nat Genet 2001 28 241-251 10.1038/90074 11431694
36. Muller-Pillasch F Wallrapp C Bartels K Varga G Friess H Buchler M Adler G Gress TM Cloning of a new Kunitz-type protease inhibitor with a putative transmembrane domain overexpressed in pancreatic cancer Biochim Biophys Acta 1998 1395 88-95 9434156
37. Suzuki M Kobayashi H Tanaka Y Hirashima Y Kanayama N Takei Y Saga Y Suzuki M Itoh H Terao T Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin Int J Cancer 2003 10: 104 3 289-302 10.1002/ijc.10950
38. Yamauchi M Kataoka H Itoh H Seguchi T Hsaui Y Osada Y Hepatocyte growth factor activator inhibitor type 1 and 2 are expressed by tubular epithelium in kidney and downregulated in renal cell carcinoma J Urol 2004 171 890-896 10.1097/01.ju.0000092861.21122.d2 14713848
39. Parr C Watkins G Mansel RE Jiang WG The hepatocyte growth factor regulatory factors in human breast cancer Clin Cancer Res 2004 10 202-211 10.1158/1078-0432.CCR-0553-3 14734471
40. Beigneux AP Kosinski C Gavino B Horton JD Skarnes WC Young SG ATP-citrate lyase deficiency in the mouse J Biol Chem 2004 279 9557-9564 10.1074/jbc.M310512200 14662765
41. Kuhajda FP Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology Nutrition 2000 16 3 202-208 10.1016/ S0899-9007(99)00266-X 10705076
42. Medes G Thomas A Weinhouse S Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro Cancer Res 1953 13 27-35 13032945
43. Kuhajda FP Jenner K Wood FD Hennigar RA Jacobs LB Dick JD Pasternack GR Fatty acid synthesis: A potential selective target for antineoplastic therapy Proc Natl Acad Sci 1994 91 14 6379-6383 44205 8022791 10.1073/ pnas.91.14.6379
44. Alo' PL Visca P Marci A Mangoni A Botti C Di Tondo U Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients Cancer 1996 77 3 474-482 10.1002/ (SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K 8630954
45. Nakamura I Kimijima I Zhang GJ Onogi H Endo Y Suzuki S Tuchiya A Takenoshita S Kusakabe T Suzuki T Fatty acid synthase expression in Japanese breast carcinoma patients Int J Mol Med 1999 4 4 381-387 10493979
46. Jensen V Ladekarl M Holm-Nielsen P Melsen F Soerensen FB The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer J Pathol 1995 176 4 343-352 10.1002/path.1711760405 7562249
47. Jensen V Ladekarl M Holm-Nielsen P Melsen F Soerensen FB Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas Tumori 1999 85 1 35-40 10.1159/000015275 10228495
48. Epstein JI Carmichael M Partin AW OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate Urology 1995 45 1 81-86 10.1016/S0090-4295(95)96904-7 7817483
49. Shurbaji MS Kalbfleisch JH Thurmond TS Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer Hum Pathol 1996 27 9 917-921 10.1016/S0046-8177(96)90218-X 8816886
50. Swinnen JV Roskams T Joniau S Van Poppel H Oyen R Baert L Heyns W Verhoeven G Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer Int J Cancer 2002 98 1 19-22 10.1002/ijc.10127 11857379
51. Gansler TS Hardman W 3rd Hunt DA Schaffel S Hennigar RA Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival Hum Pathol 1997 28 6 686-692 10.1016/ S0046-8177(97)90177-5 9191002
52. Pizer ES Lax SF Kuhajda FP Pasternack GR Kurman RJ Fatty acid synthase expression in endometrial carcinoma: Correlation with cell proliferation and hormone receptors Cancer 1998 83 3 528-537 10.1002/ (SICI)1097-0142(19980801)83:3<528::AID-CNCR22>3.0.CO;2-X 9690546
53. Rashid A Pizer ES Moga M Milgraum LZ Zahurak M Pasternack GR Kuhajda FP Hamilton SR Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia Am J Pathol 1997 150 1 201-208 1858511 9006336
54. Krontiras H Roye GD Beenken SE Myers RB Mayo MS Peters GE Grizzle WE Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue Head Neck 1999 21 4 325-329 10.1002/ (SICI)1097-0347(199907)21:4<325::AID-HED6>3.0.CO;2-P 10376752
55. Piyathilake CJ Frost AR Manne U Bell WC Weiss H Heimburger DC Grizzle WE The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung Hum Pathol 2000 31 9 1068-1073 10.1053/hupa.2000.9842 11014573
56. Yahagi N Shimano H Hasegawa K Ohashi K Matsuzaka T Najima Y Sekiya M Tomita S Okazaki H Tamura Y Iizuka Y Ohashi K Nagai R Ishibashi S Kadowaki T Makuuchi M Ohnishi S Osuga J Yamada N Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma European Journal of Cancer 2005 41 9 1316-1322 10.1016/j.ejca.2004.12.037 15869874